Last updated 2026-07-20
Total raised
—
Stage
Pre-Funding
Founded
2016
Headcount
6
HQ
Tel Aviv-Yafo, Israel
Sector
Health Tech & Life Sciences
About
GSKure is an IP-based company that owns innovative proprietary GSK-3 peptide inhibitor drug candidates. Their 'Kure products' are based on a novel design of compounds that target a unique region at the GSK-3 protein surface, termed the substrate binding site. These substrate-competitive inhibitors (SCIs) aim to offer improved selectivity and low toxicity compared to traditional ATP-competitive inhibitors, with the goal of treating neurodegenerative disorders like Alzheimer's and Parkinson's disease. Professor Hagit Eldar-Finkelman of Tel Aviv University conducted pioneering studies in developing GSK-3 inhibitors and their therapeutic use in treating human disease.
Q&A
- What is GSKure's primary focus?
- GSKure is an IP-based company focused on developing innovative proprietary GSK-3 peptide inhibitor drug candidates for treating neurogenetic disorders.
- What is the core technology behind GSKure's Kure products?
- GSKure's Kure products are based on a novel design of substrate-competitive inhibitors (SCIs) that target a unique region at the GSK-3 protein surface, offering improved selectivity and low toxicity compared to traditional ATP-competitive inhibitors.
- When was GSKure founded?
- GSKure was founded in January 2016.
- Who is the founder and CEO of GSKure?
- The founder and CEO of GSKure is Hagit Eldar-Finkelman, Ph.D.
- In which sector does GSKure primarily operate?
- GSKure operates primarily in the Health Tech & Life Sciences sector, specifically in Pharma & Medical Biotechnology and Drugs Discovery & Development.
- What is GSKure's current funding stage?
- GSKure is currently in the Pre-Funding stage.
Team · 1
Founder · Founder & CEO
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Technologies
BiologicalsMolecules
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticalsBiotechnologyHealthcarePatients
Business model
B2B
Highlights
1 Patents
Tags
drug-discoveryneurosciencealzheimers-diseaseamyotrophic-lateral-sclerosis-alsdegenerative-diseasesdrug-designpatientspharma-companies
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | gskure.com/ |
|---|
Identifiers & details
| Former names | Cerebramed |
|---|---|
| Founded | 2016-1 |
| Employees (exact) | 6 |
Radar intelligence
Web history (Wayback)
| Domain | gskure.com |
|---|
Certificate / subdomain footprint
| Subdomains | 0 |
|---|
Israeli Companies Registrar (רשם החברות / ICA)
| Registrar # (ח.פ.) | 515618676 |
|---|---|
| Status | פעילה |
| Corp type | ישראלית חברה פרטית |
| Incorporated | 2017-02-27 |
| Purpose | לעסוק בסוגי עיסוק שפורטו בתקנון |
| Liability | מוגבלת |
| In violation (unfiled) | no |
| Last annual report | 2024 |
| Active charges / liens | 0 |
| Registry events | 0 |
| Registered address | שד עמק איילון 61 שוהם |